NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) Return on Sales [ROS] (2019 - 2023)

Updated

NovaBridge Biosciences' Return on Sales [ROS] came in at -789260.00% for Q4 2023, down 785884.13 percentage points from the prior quarter.

Analysis

NovaBridge Biosciences (NBP) Return on Sales [ROS] (2019 - 2023) Analysis & Trends

For FY2023, NovaBridge Biosciences' Return on Sales [ROS] was -11395.09%, down 7972.92 percentage points from FY2022.

  • Return on Sales [ROS] has declined in each of the last three years, with a five-year change of -10579.49 percentage points (FY2018 to FY2023).
  • Going back by year, Return on Sales [ROS] was -3422.18% in FY2022 (-1097.39 pp), -2324.79% in FY2021 (-2319.51 pp), -5.27% in FY2020 (+4878.23 pp) and -4883.50% in FY2019 (-4067.90 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -789,260.00%
Sep 30, 2023 -3,375.87%
Jun 30, 2023 -7,578.62%
Dec 31, 2020 60.24%
Sep 30, 2019 -2,042.94%
API Access

NovaBridge Biosciences Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NBP&period=max&api_key=YOUR_API_KEY